当前位置:首页 - 行情中心 - 万孚生物(300482) - 财务分析

万孚生物

(300482)

  

流通市值:67.05亿  总市值:73.13亿
流通股本:4.29亿   总股本:4.68亿

万孚生物(300482)财务分析

利润表
报告期2026-09-302026-06-302026-03-312025-12-31
营业总收入1,568,892,198.991,038,506,474.79581,742,751.092,086,830,072.65
营业总成本1,453,233,686.87924,188,328.32491,970,446.342,249,566,528.36
其他经营收益
营业利润159,071,016.38142,567,604.2597,917,656.29-110,415,843.1
利润总额150,429,143.55140,553,784.8897,178,541.97-114,693,306.93
净利润138,165,819.67125,155,264.0686,122,468.23-69,658,473.46
每股收益
其他综合收益-17,212,215.47,017,702.4618,116,871.3342,498,484.27
综合收益总额120,953,604.27132,172,966.52104,239,339.56-27,159,989.19
资产负债表
报告期2026-09-302026-06-302026-03-312025-12-31
流动资产:
流动资产合计3,566,588,480.453,775,264,539.973,456,884,307.573,301,305,228.24
非流动资产:
非流动资产合计2,471,497,268.082,965,382,068.983,277,283,824.73,300,371,989.71
资产总计6,038,085,748.536,740,646,608.956,734,168,132.276,601,677,217.95
流动负债:
流动负债合计485,700,636.91,138,710,676.621,072,683,956.681,038,875,368.86
非流动负债:
非流动负债合计85,574,358.2293,612,631.0683,664,022.8589,242,035.91
负债合计571,274,995.121,232,323,307.681,156,347,979.531,128,117,404.77
所有者权益(或股东权益):
归属于母公司股东权益合计5,403,590,807.515,446,757,020.895,517,163,417.515,414,625,996.42
股东权益合计5,466,810,753.415,508,323,301.275,577,820,152.745,473,559,813.18
负债和股东权益合计6,038,085,748.536,740,646,608.956,734,168,132.276,601,677,217.95
现金流量表
报告期2026-09-302026-06-302026-03-312025-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,769,653,555.161,245,535,778.19602,273,018.232,511,134,882.94
经营活动现金流出小计1,265,351,905.94821,537,415.07384,103,290.172,048,097,322.09
经营活动产生的现金流量净额504,301,649.22423,998,363.12218,169,728.06463,037,560.85
投资活动产生的现金流量:
投资活动现金流入小计4,623,358,510.172,827,353,191.681,607,461,222.844,661,584,129.73
投资活动现金流出小计4,536,272,344.613,306,393,453.281,916,196,520.185,079,044,103
投资活动产生的现金流量净额87,086,165.56-479,040,261.6-308,735,297.34-417,459,973.27
筹资活动产生的现金流量:
筹资活动现金流入小计1,969,515.731,374,277.71653,096.587,046,953.46
筹资活动现金流出小计788,567,244.18102,664,544.180417,389,617.13
筹资活动产生的现金流量净额-786,597,728.45-101,290,266.47653,096.58-410,342,663.67
汇率变动对现金及现金等价物的影响-4,449,395.52-3,606,874.27-1,385,935.36-1,339,102.5
现金及现金等价物净增加额-199,659,309.19-159,939,039.22-91,298,408.06-366,104,178.59
期末现金及现金等价物余额262,339,540.87302,059,810.84370,700,442461,998,850.06
补充资料:
现金及现金等价物的净增加额--159,939,039.22--366,104,178.59
最新报告期:2026-10-28
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华泰证券代雯,高鹏0.440.720.852026-10-28
中信建投李虹达,王在存,贺菊颖0.620.690.762026-10-01
华创证券郑辰,李婵娟0.650.760.902026-09-30
华泰证券代雯,高鹏0.570.660.782026-08-23
TOP↑